CARE Ratings logo

CARE Ratings share news, announcements and annual reports

NSE: CARERATINGBSE: 534804Capital MarketsSmall Cap

CARE Ratings Limited · Formerly Credit Analysis and Research · Face value ₹10 · Listed Dec 2012
Last close ₹1,658.00up ₹37.80 (2.33%)BSE ₹1,658.55

Share price at the NSE close on 30 Oct 2026. Previous close ₹1,620.20.

30 Oct: open ₹1,685.00, high ₹1,709.90, low ₹1,629.00

52-week range of traded prices to 30 Oct 2026
₹1,392.70Low, 23 Mar 2026₹1,838.00High, 15 May 2026
Market cap
₹4,994 Cr794th largest listed
P/E
25.90
P/B
4.98
Dividend yield
1.33%
ROE
20.7%
ROCE
20.2%
Debt to equity
0.00
Volume, NSE
1,28,26741.0% delivered

CARE Ratings board meetings

108 filed, newest first. Page 3 of 3.

  1. Dec 2013

    • 3 Dec · Board meeting

      That the Board of Directors of the Company at its meeting held on December 03, 2013 : 1. Appointed Shri A. K. Bansal as an additional director of the Company till the next Annual General Meeting. 2. Shri O. V. Bundellu, Chairman has resigned from the Board of Directors of the Company on December 03, 2013. 3. Shri A. K. Bansal is appointed as the Independent / Non-Executive Chairman of the Board of Directors of the Company on December 03, 2013.
  2. Oct 2013

  3. Sep 2013

  4. Jul 2013

    • 24 Jul · Board meeting

      Inter-alia, to consider the Unaudited Financial Results for the first quarter of FY 2013-14 ended June 30, 2013.
  5. Apr 2013

    • 30 Apr · Board meeting

      Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 06, 2013 to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2013 and to recommend dividend, if any, on the equity shares of the Company for the financial Year 2012-13. The Company has now informed the Exchange that the aforesaid Board Meeting has been re-scheduled to be held on May 15, 2013 instead of May 06, 2013.

      Not held on this date

    • 27 Apr · Board meeting

      To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2013 and to recommend dividend, if any, on the equity shares of the Company for the financial Year 2012-13.
  6. Feb 2013

    • 13 Feb · Board meeting

      Inter alia, to consider the declaration of Interim Dividend, if any, for the financial year 2012-13.
  7. Jan 2013

    • 15 Jan · Board meeting

      To consider the Unaudited Financial Results for the Third Quarter ended December 31, 2012.